We evaluated the possibility to employ a Machine Learning approach to assess the dose-dependency of antidepressants, with distinct mechanisms of action: fluoxetine and maprotiline in wild-type C57BL/6 mice.
This new analysis pipeline provides a tool to more quickly and objectively assess the effects of compounds in development and compare them to existing reference drugs for various indications.
